Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours

Journal of Pathology

Volumn 209, Issue 4, 2006, Pages 492-500

  Storlazzi, C T ^a   Brekke, H R ^b   Mandahl, N ^c   Brosjo O ^d   Smeland, S ^b   Lothe, R A ^b   Mertens, F ^c  

^a UNIVERSITY OF BARI   (Italy)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amplification; BIRC5; FISH; MPNST; NF1

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; SURVIVIN;

ADOLESCENT; ADULT; AGED; AMPLICON; APOPTOSIS; ARTICLE; BRAIN CANCER; CARCINOGENESIS; CELL SURVIVAL; CHROMOSOME 17Q; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; MALIGNANT NEOPLASTIC DISEASE; METAPHASE; METASTASIS; NERVE CELL DIFFERENTIATION; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PERIPHERAL NERVE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 17; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; GENES, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; METAPHASE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; SARCOMA;

EID: 33746895189     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1998     Document Type: Article

References (34)

1. Stonecypher MS, Byer SJ, Grizzle WE, Carroll SL. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 2005;24:5589-5605.
2. Woodruff J. In Pathology of the Major Peripheral Nerve Sheath Neoplasms, Weiss S, Brooks J (eds). Williams & Wilkins: Baltimore, 1996; 129-161.
3. Brooks DG. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors. Neurosurg Clin N Am 2004;15:145-155.
4. Zhang YY, Vik TA, Ryder JW, Srour EF, Jacks T, Shannon K, et al. Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines. J Exp Med 1998;187:1893-1902.
5. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 197 1;68:820-823.
6. Legius E, Dierick H, Wu R, Hall BK, Marynen P, Cassiman JJ, et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 1994;10:250-255.
7. Storlazzi CT, Von Steyern FV, Domanski HA, Mandahl N, Mertens F. Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurolibroma. Int J Cancer 2005;117:1055-1057.
8. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-708.
9. Lothe RA, Smith-Sorensen B, Hektoen M, Stenwig AE, Mandahl N, Saeter G, et al. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. Genes Chromosomes Cancer 2001;30:202-206.
10. Agesen TH, Florenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, et al. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. J Neuropathol Exp Neurol 2005;64:74-81.
11. Carroll SL, Stonecypher MS. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling. J Neuropathol Exp Neurol 2005;64:1-9.
12. Berner JM, Sorlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, et al. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 1999;26:151-160.
13. Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 1999;155:1855-1860.
14. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 1999;155:1879-1884.
15. Mertens F, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, Mitelman F, et al. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 2000;190:31-39.
16. Lothe RA, Karhu R, Mandahl N, Mertens F, Saeter G, Heim S, et al. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 1996;56:4778-4781.
17. Mechtersheimer G, Otano-Joos M, Ohl S, Benner A, Lehnert T, Willeke F, et al. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1999;25:362-369.
18. Schmidt H, Wurl P, Taubert H, Meye A, Bache M, Holzhausen HJ, et al. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer 1999;25:205-211.
19. Schmidt H, Taubert H, Meye A, Wurl P, Bache M, Bartel F, et al. Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett 2000;155:181-190.
20. Schmidt H, Taubert H, Wurl P, Bache M, Bartel F, Holzhausen HJ, et al. Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 2001;128:14-23.
21. Koga T, Iwasaki H, Ishiguro M, Matsuzaki A, Kikuchi M. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J Pathol 2002;197:98-107.
22. Skotheim RI, Kallioniemi A, Bjerkhagen B, Mertens F, Brekke HR, Monni O, et al. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome. J Clin Oncol 2003;21:4586-4591.
23. Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, et al. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell 2005;7:65-75.
24. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 2000;28:425-431.
25. Lothe RA, Slettan A, Saeter G, Brogger A, Borresen AL, Nesland JM. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 1995;54:65-73.
26. Mertens F, Rydholm A, Bauer HF, Limon J, Nedoszytko B, Szadowska A, et al. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 1995;61:793-798.
27. ISCN. An International System for Human Cytogenetic Nomenclature, Mitelman F (ed). Karger: Basel, 1995.
28. Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N. Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 2004;109:363-369.
29. Altieri DC. Validating survivin as a cancer therapeutic target. Nature Rev Cancer 2003;3:46-54.
30. Wurl P, Kappler M, Meye A, Bartel F, Kohler T, Lautenschlager C, et al. Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet 2002;359:943-945.
31. Levy P, Vidaud D, Leroy K, Laurendeau I, Wechsler J, Bolasco G, et al. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol Cancer 2004;3:20.
32. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405:85-90.
33. Hall PA, Jung K, Hillan KJ, Russell SE. Expression profiling the human septin gene family. J Pathol 2005;206:269-278.
34. Yadav A, Kalita A, Banerjee K. JAK/STAT3 pathway is involved survival of neurons in response to insulin like growth factor and negatively regulated by suppression of cytokine signaling-3. J Biol Chem 2005;280:31830-31840.